Mortality and reoperation rate of biological versus mechanical Bentall-De Bono operation: a propensity-matched study

Abstract

Objective: To assess follow-up mortality and reoperation rate in patients undergoing Bentall-De Bono operation according to the type of composite valve graft used.

Methods: All consecutive adult patients operated on between May 1997 and December 2019 at our institution were included in the analysis and classified according to the use of a biological or a mechanical composite valve graft (bCVG or mCVG). The primary outcomes were follow-up mortality and reoperation rate. Secondary outcomes were operative mortality and major adverse events (MAEs) including operative mortality, myocardial infarction, cerebrovascular accident, dialysis, tracheostomy, and re-exploration for bleeding. Kaplan-Meier and competing risk analyses were used. Propensity matching analysis was used to balance differences in baseline characteristics between procedures.

Results: Of 1,210 included patients, 798 received a bCVG and 412 a mCVG. The mean follow-up was 6.64 ± 0.21 years. The ten-year mortality rate was higher in the mCVG group (25.3% vs. 16.4%, P = 0.023). The ten-year reoperation rate was higher in the bCVG group (7.4% vs. 1.1%, P < 0.001). Overall operative mortality was 0.7%, and MAEs occurred in 6.2% of patients, with no significant differences between groups. Older age (hazard ratio [HR] 1.06, 95% confidence interval [CI: 1.04-1.08], P < 0.01), chronic obstructive pulmonary disease (HR 1.63, 95%CI: [1.01-2.64], P = 0.04), preoperative renal dysfunction (HR 3.08, 95%CI: [1.98-4.78], P < 0.001), New York Heart Association Class III/IV (HR 1.48, 95%CI: [1.04-2.10], P = 0.031), and mCVG (HR 2.15, 95%CI: [1.42-3.26], P < 0.001) were associated with higher risk of follow-up mortality. After propensity matching, the differences in mortality and reoperation remained significant.

Conclusions: The Bentall-De Bono operation can be performed with consistently good results in experienced centers. Early outcomes are excellent regardless of the valve choice. In our study, the Bentall-De Bono operation with bCVG was associated with lower 10-year mortality but carried a higher risk of aortic reoperation. While the risk of reoperation is largely tied to valve choice, follow-up mortality is more likely to be influenced by patient comorbidities and risk factors.

Keywords

Aortic root surgery / mechanical prosthesis / biological valve / composite valve graft / Bentall-De Bono / survival / reoperation

References

[1] Etz CD,Bodian C.The bentall procedure: is it the gold standard?.J Thorac Cardiovasc Surg2010;140:S64-70; discussion S86

[2] Otto CM,Bonow RO.2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the american college of cardiology/American heart association joint committee on clinical practice guidelines.Circulation2021;143:e72-e227

[3] Vahanian A,Praz F.2021 ESC/EACTS guidelines for the management of valvular heart disease.Eur Heart J2022;43:561-632

[4] Gaudino M,Munjal M,Girardi LN.Contemporary outcomes of surgery for aortic root aneurysms: a propensity-matched comparison of valve-sparing and composite valve graft replacement.J Thorac Cardiovasc Surg2015;150:1120-9.e1

[5] Head SJ,Kappetein AP.Mechanical versus bioprosthetic aortic valve replacement.Eur Heart J2017;38:2183-91

[6] Head SJ.Aortic valve replacement in younger adults: a biological valve is not the logical choice.Eur Heart J2016;37:2668-70

[7] Girardi LN.Composite root replacement with a mechanical conduit.Oper Tech Thorac Cardiovasc Surg2008;13:148-60

[8] Lau C,Iannacone EM.Retrograde cerebral perfusion is effective for prolonged circulatory arrest in arch aneurysm repair.Ann Thorac Surg2018;105:491-7

[9] Kouchoukos NT.Resection of ascending aortic aneurysm and replacement of aortic valve.J Thorac Cardiovasc Surg1981;81:142-3

[10] Fine JP.A proportional hazards model for the subdistribution of a competing risk.J Am Stat Assoc1999;94:496-509

[11] Dunning J,Chambers J.Aortic valve surgery: marked increases in volume and significant decreases in mechanical valve use-an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database.J Thorac Cardiovasc Surg2011;142:776-782.e3

[12] Siregar S,Groenwold RH.Trends and outcomes of valve surgery: 16-year results of Netherlands Cardiac Surgery National Database.Eur J Cardiothorac Surg2014;46:386-97; discussion 397

[13] Isaacs AJ,Salemi A,Sedrakyan A.National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements.J Thorac Cardiovasc Surg2015;149:1262-9.e3

[14] Wright JN,Kim K,Witt DM.Assessing patient preferences for switching from warfarin to direct oral anticoagulants.J Thromb Thrombolysis2019;48:596-602

[15] Glaser N,Holzmann MJ,Sartipy U.Aortic valve replacement with mechanical vs. biological prostheses in patients aged 50-69 years.Eur Heart J2016;37:2658-67

[16] Brown ML,Lahr BD.Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses.J Thorac Cardiovasc Surg2008;135:878-84; discussion 884

[17] Svensson LG,Rajeswaran J.Long-term survival, valve durability, and reoperation for 4 aortic root procedures combined with ascending aorta replacement.J Thorac Cardiovasc Surg2016;151:764-774.e4 PMCID:PMC5125725

[18] Etz CD,von Aspern K.Longevity after aortic root replacement: is the mechanically valved conduit really the gold standard for quinquagenarians?.Circulation2013;128:S253-62

[19] Kytö V,Ahtela E,Gunn J.Mechanical versus biologic prostheses for surgical aortic valve replacement in patients aged 50 to 70.Ann Thorac Surg2020;110:102-10

[20] Pantaleo A,Di Marco L.Biological versus mechanical Bentall procedure for aortic root replacement: a propensity score analysis of a consecutive series of 1112 patients.Eur J Cardiothorac Surg2017;52:143-9